ABCC1 and acute myeloid leukemia: In conclusion, this work proposes ABCC1 as a functional biomarker for the response of AML cells to BH3 mimetics and suggests interference with ABCC1 function or GSH homeostasis as rational strategies to overcome Venetoclax resistance.